ASP Isotopes (ASPI) announced that a UK subsidiary of Quantum Leap Energy, a wholly-owned subsidiary of ASPI, has commenced a strategic collaboration with the University of Bristol for the design of a lithium laser research facility in the UK. Under the terms of the agreement, the University of Bristol will lead the design and feasibility study for a site-agnostic laser enrichment research facility over an estimated four-month initial phase. The project involves desk-based concept design work, engineering specifications, and safety reviews to establish the foundation for a research hub. Subject to a positive feasibility assessment, the parties intend to proceed with construction of the facility at a suitable University of Bristol site off-campus where it will enable cutting-edge research commissioned and funded by QLE.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ASPI:
- ASP Isotopes: Strategic Nuclear Partnerships Strengthen HALEU Supply Chain Position and Support Buy Rating
- ASP Isotopes Inc call volume above normal and directionally bullish
- Midday Fly By: Rising oil prices, falling employment sink stocks
- ASP Isotopes announces Quantum Leap enters MOU with U.S. energy company
- ASP Isotopes’ Quantum Leap appoints Nate Salpeter as CTO
